APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Inhalation Pulmonary Drug Delivery Devices

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Inhalation Pulmonary Drug Delivery Devices Industry Growth and Trends Forecast to 2032

Report ID 174002830128 December 2025116 pages

Choose your research edition.

Industry ResearchInhalation Pulmonary Drug Delivery Devices Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhalation Pulmonary Drug Delivery Devices Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Inhalation Pulmonary Drug Delivery Devices Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhalation Pulmonary Drug Delivery Devices Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhalation Pulmonary Drug Delivery Devices Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Inhalation Pulmonary Drug Delivery Devices market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhalation Pulmonary Drug Delivery Devices is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Inhalation Pulmonary Drug Delivery Devices include AptarGroup, Boehringer Ingelheim, Chiesi Farmaceutici, H&T Presspart, Koninklijke Philips, Monaghan Medical, OMRON, PARI International and Vectura, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Inhalation Pulmonary Drug Delivery Devices market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Inhalation Pulmonary Drug Delivery Devices market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Inhalation Pulmonary Drug Delivery Devices market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Inhalation Pulmonary Drug Delivery Devices.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Inhalation Pulmonary Drug Delivery Devices market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Inhalation Pulmonary Drug Delivery Devices Market by Company

AptarGroup

Boehringer Ingelheim

Chiesi Farmaceutici

H&T Presspart

Koninklijke Philips

Monaghan Medical

OMRON

PARI International

Vectura

AstraZeneca

GlaxoSmithKline (GSK)

Viatris

Merck

Novartis

Teva Pharmaceutical Industries

Inhalation Pulmonary Drug Delivery Devices Segment by Type

Nebulizers

Dry-powder Inhalers

Metered- dose Inhalers

Inhalation Pulmonary Drug Delivery Devices Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis (CF)

Idiopathic Pulmonary Fibrosis (IPF)

Asthma

Others

Inhalation Pulmonary Drug Delivery Devices Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhalation Pulmonary Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhalation Pulmonary Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhalation Pulmonary Drug Delivery Devices.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Inhalation Pulmonary Drug Delivery Devices manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Inhalation Pulmonary Drug Delivery Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Nebulizers Table 2. Major Company of Dry-powder Inhalers Table 3. Major Company of Metered- dose Inhalers Table 4. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 6. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type (2021-2026) Table 7. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 8. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Type (2021-2026) Table 9. Global Inhalation Pulmonary Drug Delivery Devices Price by Type (2021-2026) & (US$/Unit) Table 10. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (K Units) Table 11. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type (2027-2032) Table 12. Global Inhalation Pulmonary Drug Delivery Devices Sales by Type (2027-2032) & (US$ Million) Table 13. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Type (2027-2032) Table 14. Global Inhalation Pulmonary Drug Delivery Devices Price by Type (2027-2032) & (US$/Unit) Table 15. North America Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 16. North America Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 18. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 22. Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Type (2021-2026) & (US$ Million) Table 25. Inhalation Pulmonary Drug Delivery Devices Industry Trends Table 26. Inhalation Pulmonary Drug Delivery Devices Industry Drivers Table 27. Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges Table 28. Inhalation Pulmonary Drug Delivery Devices Industry Restraints Table 29. Global Inhalation Pulmonary Drug Delivery Devices Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Inhalation Pulmonary Drug Delivery Devices Revenue Market Share by Company (2021-2026) Table 31. Global Inhalation Pulmonary Drug Delivery Devices Sales by Company (2021-2026) & (K Units) Table 32. Global Inhalation Pulmonary Drug Delivery Devices Sales Share by Company (2021-2026) Table 33. Global Inhalation Pulmonary Drug Delivery Devices Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Inhalation Pulmonary Drug Delivery Devices Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Inhalation Pulmonary Drug Delivery Devices Major Company Production Sites and Headquarters Table 36. Global Inhalation Pulmonary Drug Delivery Devices Company, Product Type & Application Table 37. Global Inhalation Pulmonary Drug Delivery Devices Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Inhalation Pulmonary Drug Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Inhalation Pulmonary Drug Delivery Devices Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2026) & (K Units) Table 42. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Region (2021-2026) Table 43. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2021-2026) & (US$ Million) Table 44. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Region (2021-2026) Table 45. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2027-2032) & (K Units) Table 47. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Region (2027-2032) Table 48. Global Inhalation Pulmonary Drug Delivery Devices Sales by Region (2027-2032) & (US$ Million) Table 49. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Region (2027-2032) Table 50. Global Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 53. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application (2021-2026) Table 54. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 55. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Application (2021-2026) Table 56. Global Inhalation Pulmonary Drug Delivery Devices Price by Application (2021-2026) & (US$/Unit) Table 57. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (K Units) Table 58. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application (2027-2032) Table 59. Global Inhalation Pulmonary Drug Delivery Devices Sales by Application (2027-2032) & (US$ Million) Table 60. Global Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Application (2027-2032) Table 61. Global Inhalation Pulmonary Drug Delivery Devices Price by Application (2027-2032) & (US$/Unit) Table 62. North America Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 63. North America Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 65. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 69. Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Application (2021-2026) & (US$ Million) Table 72. AptarGroup Company Information Table 73. AptarGroup Business Overview Table 74. AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 76. AptarGroup Recent Development Table 77. Boehringer Ingelheim Company Information Table 78. Boehringer Ingelheim Business Overview Table 79. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 81. Boehringer Ingelheim Recent Development Table 82. Chiesi Farmaceutici Company Information Table 83. Chiesi Farmaceutici Business Overview Table 84. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 86. Chiesi Farmaceutici Recent Development Table 87. H&T Presspart Company Information Table 88. H&T Presspart Business Overview Table 89. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 91. H&T Presspart Recent Development Table 92. Koninklijke Philips Company Information Table 93. Koninklijke Philips Business Overview Table 94. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 96. Koninklijke Philips Recent Development Table 97. Monaghan Medical Company Information Table 98. Monaghan Medical Business Overview Table 99. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 101. Monaghan Medical Recent Development Table 102. OMRON Company Information Table 103. OMRON Business Overview Table 104. OMRON Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 106. OMRON Recent Development Table 107. PARI International Company Information Table 108. PARI International Business Overview Table 109. PARI International Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 111. PARI International Recent Development Table 112. Vectura Company Information Table 113. Vectura Business Overview Table 114. Vectura Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 116. Vectura Recent Development Table 117. AstraZeneca Company Information Table 118. AstraZeneca Business Overview Table 119. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 121. AstraZeneca Recent Development Table 122. GlaxoSmithKline (GSK) Company Information Table 123. GlaxoSmithKline (GSK) Business Overview Table 124. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 126. GlaxoSmithKline (GSK) Recent Development Table 127. Viatris Company Information Table 128. Viatris Business Overview Table 129. Viatris Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 131. Viatris Recent Development Table 132. Merck Company Information Table 133. Merck Business Overview Table 134. Merck Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 136. Merck Recent Development Table 137. Novartis Company Information Table 138. Novartis Business Overview Table 139. Novartis Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 141. Novartis Recent Development Table 142. Teva Pharmaceutical Industries Company Information Table 143. Teva Pharmaceutical Industries Business Overview Table 144. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio Table 146. Teva Pharmaceutical Industries Recent Development Table 147. North America Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 149. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2026) Table 150. North America Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 151. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 152. North America Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. North America Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 154. North America Inhalation Pulmonary Drug Delivery Devices Market Share by Country (2021-2026) Table 155. North America Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. North America Inhalation Pulmonary Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 157. Europe Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 159. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2026) Table 160. Europe Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 161. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 162. Europe Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 164. Europe Inhalation Pulmonary Drug Delivery Devices Market Share by Country (2021-2026) Table 165. Europe Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Europe Inhalation Pulmonary Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 169. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2026) Table 170. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 171. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 172. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 174. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Share by Country (2021-2026) Table 175. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 177. Latin America Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 179. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2026) Table 180. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 181. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 182. Latin America Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Latin America Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 184. Latin America Inhalation Pulmonary Drug Delivery Devices Market Share by Country (2021-2026) Table 185. Latin America Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Latin America Inhalation Pulmonary Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026) & (K Units) Table 189. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share by Country (2021-2026) Table 190. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032) & (K Units) Table 191. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share Forecast by Country (2027-2032) Table 192. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 193. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026) & (US$ Million) Table 194. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Share by Country (2021-2026) Table 195. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032) & (US$ Million) Table 196. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Share Forecast by Country (2027-2032) Table 197. Key Raw Materials Table 198. Raw Materials Key Suppliers Table 199. Inhalation Pulmonary Drug Delivery Devices Distributors List Table 200. Inhalation Pulmonary Drug Delivery Devices Customers List Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Inhalation Pulmonary Drug Delivery Devices Image Figure 2. Global Inhalation Pulmonary Drug Delivery Devices Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhalation Pulmonary Drug Delivery Devices Market Size (2021-2032) & (US$ Million) Figure 4. Global Inhalation Pulmonary Drug Delivery Devices Sales (2021-2032) & (K Units) Figure 5. Nebulizers Image Figure 6. Global Nebulizers Sales YoY Growth (2021-2032) & (K Units) Figure 7. Dry-powder Inhalers Image Figure 8. Global Dry-powder Inhalers Sales YoY Growth (2021-2032) & (K Units) Figure 9. Metered- dose Inhalers Image Figure 10. Global Metered- dose Inhalers Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Inhalation Pulmonary Drug Delivery Devices Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Inhalation Pulmonary Drug Delivery Devices Market Share by Type 2025 VS 2032 Figure 13. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 14. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Type in 2025 Figure 15. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 16. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Type in 2025 Figure 19. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Inhalation Pulmonary Drug Delivery Devices Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 26. Global Chronic Obstructive Pulmonary Disease (COPD) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Cystic Fibrosis (CF) Image Figure 28. Global Cystic Fibrosis (CF) Sales YoY Growth (2021-2032) & (K Units) Figure 29. Idiopathic Pulmonary Fibrosis (IPF) Image Figure 30. Global Idiopathic Pulmonary Fibrosis (IPF) Sales YoY Growth (2021-2032) & (K Units) Figure 31. Asthma Image Figure 32. Global Asthma Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Inhalation Pulmonary Drug Delivery Devices Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Inhalation Pulmonary Drug Delivery Devices Market Share by Application 2025 VS 2032 Figure 37. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 38. North America Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Application in 2025 Figure 39. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 40. Europe Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Application in 2025 Figure 43. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Market Share in Value by Application in 2025 Figure 47. North America Inhalation Pulmonary Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Inhalation Pulmonary Drug Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Inhalation Pulmonary Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Inhalation Pulmonary Drug Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Inhalation Pulmonary Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Inhalation Pulmonary Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Inhalation Pulmonary Drug Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Inhalation Pulmonary Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Inhalation Pulmonary Drug Delivery Devices Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Inhalation Pulmonary Drug Delivery Devices Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Nebulizers
  • Dry-powder Inhalers
  • Metered- dose Inhalers
Applications
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Asthma
  • Others
Companies covered
  • AptarGroup
  • Boehringer Ingelheim
  • Chiesi Farmaceutici
  • H&T Presspart
  • Koninklijke Philips
  • Monaghan Medical
  • OMRON
  • PARI International
  • Vectura
  • AstraZeneca
  • GlaxoSmithKline (GSK)
  • Viatris
  • Merck
  • Novartis
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Inhalation Pulmonary Drug Delivery Devices Market by Type
  6. 1.3.1 Nebulizers
  7. 1.3.2 Dry-powder Inhalers
  8. 1.3.3 Metered- dose Inhalers
  9. 1.4 Global Inhalation Pulmonary Drug Delivery Devices Market Size by Type
  10. 1.4.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Inhalation Pulmonary Drug Delivery Devices Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Inhalation Pulmonary Drug Delivery Devices Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Inhalation Pulmonary Drug Delivery Devices Industry Trends
  2. 2.2 Inhalation Pulmonary Drug Delivery Devices Industry Drivers
  3. 2.3 Inhalation Pulmonary Drug Delivery Devices Industry Opportunities and Challenges
  4. 2.4 Inhalation Pulmonary Drug Delivery Devices Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Inhalation Pulmonary Drug Delivery Devices Revenue (2021-2026)
  2. 3.2 Global Top Players by Inhalation Pulmonary Drug Delivery Devices Sales (2021-2026)
  3. 3.3 Global Top Players by Inhalation Pulmonary Drug Delivery Devices Price (2021-2026)
  4. 3.4 Global Inhalation Pulmonary Drug Delivery Devices Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Inhalation Pulmonary Drug Delivery Devices Major Company Production Sites & Headquarters
  6. 3.6 Global Inhalation Pulmonary Drug Delivery Devices Company, Product Type & Application
  7. 3.7 Global Inhalation Pulmonary Drug Delivery Devices Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Inhalation Pulmonary Drug Delivery Devices Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Inhalation Pulmonary Drug Delivery Devices Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Inhalation Pulmonary Drug Delivery Devices Tier 1, Tier 2, and Tier 3
4 Inhalation Pulmonary Drug Delivery Devices Regional Status and Outlook
  1. 4.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Inhalation Pulmonary Drug Delivery Devices Historic Market Size by Region
  3. 4.2.1 Global Inhalation Pulmonary Drug Delivery Devices Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Inhalation Pulmonary Drug Delivery Devices Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Inhalation Pulmonary Drug Delivery Devices Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Inhalation Pulmonary Drug Delivery Devices Forecasted Market Size by Region
  7. 4.3.1 Global Inhalation Pulmonary Drug Delivery Devices Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Inhalation Pulmonary Drug Delivery Devices Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Inhalation Pulmonary Drug Delivery Devices Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Inhalation Pulmonary Drug Delivery Devices by Application
  1. 5.1 Inhalation Pulmonary Drug Delivery Devices Market by Application
  2. 5.1.1 Chronic Obstructive Pulmonary Disease (COPD)
  3. 5.1.2 Cystic Fibrosis (CF)
  4. 5.1.3 Idiopathic Pulmonary Fibrosis (IPF)
  5. 5.1.4 Asthma
  6. 5.1.5 Others
  7. 5.2 Global Inhalation Pulmonary Drug Delivery Devices Market Size by Application
  8. 5.2.1 Global Inhalation Pulmonary Drug Delivery Devices Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Inhalation Pulmonary Drug Delivery Devices Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Inhalation Pulmonary Drug Delivery Devices Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AptarGroup
  2. 6.1.1 AptarGroup Company Information
  3. 6.1.2 AptarGroup Business Overview
  4. 6.1.3 AptarGroup Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AptarGroup Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  6. 6.1.5 AptarGroup Recent Developments
  7. 6.2 Boehringer Ingelheim
  8. 6.2.1 Boehringer Ingelheim Company Information
  9. 6.2.2 Boehringer Ingelheim Business Overview
  10. 6.2.3 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Boehringer Ingelheim Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  12. 6.2.5 Boehringer Ingelheim Recent Developments
  13. 6.3 Chiesi Farmaceutici
  14. 6.3.1 Chiesi Farmaceutici Company Information
  15. 6.3.2 Chiesi Farmaceutici Business Overview
  16. 6.3.3 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Chiesi Farmaceutici Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  18. 6.3.5 Chiesi Farmaceutici Recent Developments
  19. 6.4 H&T Presspart
  20. 6.4.1 H&T Presspart Company Information
  21. 6.4.2 H&T Presspart Business Overview
  22. 6.4.3 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 H&T Presspart Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  24. 6.4.5 H&T Presspart Recent Developments
  25. 6.5 Koninklijke Philips
  26. 6.5.1 Koninklijke Philips Company Information
  27. 6.5.2 Koninklijke Philips Business Overview
  28. 6.5.3 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Koninklijke Philips Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  30. 6.5.5 Koninklijke Philips Recent Developments
  31. 6.6 Monaghan Medical
  32. 6.6.1 Monaghan Medical Company Information
  33. 6.6.2 Monaghan Medical Business Overview
  34. 6.6.3 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Monaghan Medical Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  36. 6.6.5 Monaghan Medical Recent Developments
  37. 6.7 OMRON
  38. 6.7.1 OMRON Company Information
  39. 6.7.2 OMRON Business Overview
  40. 6.7.3 OMRON Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 OMRON Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  42. 6.7.5 OMRON Recent Developments
  43. 6.8 PARI International
  44. 6.8.1 PARI International Company Information
  45. 6.8.2 PARI International Business Overview
  46. 6.8.3 PARI International Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 PARI International Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  48. 6.8.5 PARI International Recent Developments
  49. 6.9 Vectura
  50. 6.9.1 Vectura Company Information
  51. 6.9.2 Vectura Business Overview
  52. 6.9.3 Vectura Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Vectura Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  54. 6.9.5 Vectura Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
  61. 6.11 GlaxoSmithKline (GSK)
  62. 6.11.1 GlaxoSmithKline (GSK) Company Information
  63. 6.11.2 GlaxoSmithKline (GSK) Business Overview
  64. 6.11.3 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 GlaxoSmithKline (GSK) Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  66. 6.11.5 GlaxoSmithKline (GSK) Recent Developments
  67. 6.12 Viatris
  68. 6.12.1 Viatris Company Information
  69. 6.12.2 Viatris Business Overview
  70. 6.12.3 Viatris Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Viatris Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  72. 6.12.5 Viatris Recent Developments
  73. 6.13 Merck
  74. 6.13.1 Merck Company Information
  75. 6.13.2 Merck Business Overview
  76. 6.13.3 Merck Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Merck Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  78. 6.13.5 Merck Recent Developments
  79. 6.14 Novartis
  80. 6.14.1 Novartis Company Information
  81. 6.14.2 Novartis Business Overview
  82. 6.14.3 Novartis Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Novartis Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  84. 6.14.5 Novartis Recent Developments
  85. 6.15 Teva Pharmaceutical Industries
  86. 6.15.1 Teva Pharmaceutical Industries Company Information
  87. 6.15.2 Teva Pharmaceutical Industries Business Overview
  88. 6.15.3 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Teva Pharmaceutical Industries Inhalation Pulmonary Drug Delivery Devices Product Portfolio
  90. 6.15.5 Teva Pharmaceutical Industries Recent Developments
7 North America by Country
  1. 7.1 North America Inhalation Pulmonary Drug Delivery Devices Sales by Country
  2. 7.1.1 North America Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026)
  4. 7.1.3 North America Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032)
  5. 7.2 North America Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  6. 7.2.1 North America Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026)
  8. 7.2.3 North America Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country
  2. 8.1.1 Europe Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026)
  4. 8.1.3 Europe Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  6. 8.2.1 Europe Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026)
  8. 8.2.3 Europe Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country
  2. 9.1.1 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  6. 9.2.1 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Inhalation Pulmonary Drug Delivery Devices Sales by Country
  2. 10.1.1 South America Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026)
  4. 10.1.3 South America Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032)
  5. 10.2 South America Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  6. 10.2.1 South America Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026)
  8. 10.2.3 South America Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country
  2. 11.1.1 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size by Country
  6. 11.2.1 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Inhalation Pulmonary Drug Delivery Devices Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Inhalation Pulmonary Drug Delivery Devices Value Chain Analysis
  2. 12.1.1 Inhalation Pulmonary Drug Delivery Devices Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Inhalation Pulmonary Drug Delivery Devices Production Mode & Process
  7. 12.2 Inhalation Pulmonary Drug Delivery Devices Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Inhalation Pulmonary Drug Delivery Devices Distributors
  10. 12.2.3 Inhalation Pulmonary Drug Delivery Devices Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst